메뉴 건너뛰기




Volumn 91, Issue 4, 2001, Pages 550-554

Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody β-glucuronidase conjugate

Author keywords

ADEPT; Anthracyclines; Antibody directed enzyme prodrug therapy; Selective chemotherapy

Indexed keywords

BETA GLUCURONIDASE; CARBAMIC ACID DERIVATIVE; CELL ADHESION MOLECULE; DOXORUBICIN; MONOCLONAL ANTIBODY; N [4 DOXORUBICIN N CARBONYL(OXYMETHY)PHENYL] O BETA GLUCURONYLCARBAMATE; PRODRUG; UNCLASSIFIED DRUG;

EID: 0035866038     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1075>3.0.CO;2-L     Document Type: Article
Times cited : (56)

References (28)
  • 10
    • 0030250635 scopus 로고    scopus 로고
    • Improved characteristics of a human β-glucuronidase-antibody conjugate after deglycosylation for use in antibody-directed enzyme prodrug therapy
    • (1996) Bioconjug Chem , vol.7 , pp. 606-611
    • Houba, P.H.1    Boven, E.2    Haisma, H.J.3
  • 11
    • 0002931023 scopus 로고
    • β-glucuronidase and the hydrolysis of glucuronides
    • Dutton GJ, editor. Glucuronic acid, free and combined. New York: Academic Press
    • (1966) , pp. 301-364
    • Levvy, G.A.1    Conchie, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.